Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity.


Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
28 05 2019
Historique:
received: 28 11 2018
revised: 08 02 2019
accepted: 14 02 2019
pubmed: 23 2 2019
medline: 6 2 2020
entrez: 22 2 2019
Statut: ppublish

Résumé

Cancer stem cells, also known as tumor-initiating cells (TICs), are a population of aggressive and self-renewing cells that are responsible for the initiation and progression of many cancers, including colorectal carcinoma. Intratumoral hypoxia, i.e. reduced oxygen supply following uncontrolled proliferation of cancer cells, is thought to support TIC activity by inducing specific hypoxia-responsive mechanisms that are not yet entirely understood. Using previously established and fully characterized patient-derived TIC cultures, we could observe increased sphere and colony formation under hypoxic conditions. Mechanistically, microRNA (miRNA)-profiling experiments allowed us to identify miR-215 as one of the main hypoxia-induced miRNAs in primary colon TICs. Through stable overexpression of miR-215, followed by a set of functional in vitro and in vivo investigations, miR-215 was pinpointed as a negative feedback regulator, working against the TIC-promoting effects of hypoxia. Furthermore, we could single out LGR5, a bona fide marker of non-neoplastic intestinal stem cells, as a downstream target of hypoxia/miR-215 signaling. The strong tumor- and TIC-suppressor potential of miR-215 and the regulatory role of the hypoxia/miR-215/LGR5 axis may thus represent interesting points of attack for the development of innovative anti-CSC therapy approaches.

Identifiants

pubmed: 30790680
pii: S0304-3835(19)30108-9
doi: 10.1016/j.canlet.2019.02.030
pii:
doi:

Substances chimiques

LGR5 protein, human 0
MIRN215 microRNA, human 0
MicroRNAs 0
Receptors, G-Protein-Coupled 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-41

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Pit Ullmann (P)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Martin Nurmik (M)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Martine Schmitz (M)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Fabien Rodriguez (F)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Jil Weiler (J)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Komal Qureshi-Baig (K)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Paul Felten (P)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Petr V Nazarov (PV)

Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, 1A-B Rue Thomas Edison, L-1445, Strassen, Luxembourg.

Nathalie Nicot (N)

Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, 1A-B Rue Thomas Edison, L-1445, Strassen, Luxembourg.

Nikolaus Zuegel (N)

Centre Hospitalier Emile Mayrisch, Rue Emile Mayrisch, L-4240, Esch-sur-Alzette, Luxembourg.

Serge Haan (S)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg.

Elisabeth Letellier (E)

Molecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg, 6 Avenue Du Swing, L-4367, Belvaux, Luxembourg. Electronic address: elisabeth.letellier@uni.lu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH